Source: ALL

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 197370
Gene Symbol: NSMCE1
NSMCE1
CUI: C1704436
Disease: Peripheral Arterial Diseases
Peripheral Arterial Diseases 		0.100 GeneticVariation GWASCAT Genetic Variants in the Bone Morphogenic Protein Gene Family Modify the Association between Residential Exposure to Traffic and Peripheral Arterial Disease. 27082954

2016
Entrez Id: 197370
Gene Symbol: NSMCE1
NSMCE1
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease 		0.010 Biomarker BEFREE So far, there is no direct evidence for the correlation between Nsmce1 and AD. 31792732

2019
Entrez Id: 197370
Gene Symbol: NSMCE1
NSMCE1
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms 		0.010 PosttranslationalModification BEFREE The combination of NSE1 or SPOCK2 hypermethylation showed a sensitivity of 80% and specificity of 95% in differentiating cancer from normal. 18446232

2008
Entrez Id: 197370
Gene Symbol: NSMCE1
NSMCE1
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate 		0.010 Biomarker BEFREE Based on methylation in primary tumors compared to normal adjacent tissues, NKX2-5, CLSTN1, SPOCK2, SLC16A12, DPYS and NSE1 are candidate biomarkers for prostate cancer (methylation range 50%-85%). 18446232

2008
Entrez Id: 197370
Gene Symbol: NSMCE1
NSMCE1
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.010 Biomarker BEFREE Based on methylation in primary tumors compared to normal adjacent tissues, NKX2-5, CLSTN1, SPOCK2, SLC16A12, DPYS and NSE1 are candidate biomarkers for prostate cancer (methylation range 50%-85%). 18446232

2008
Entrez Id: 197370
Gene Symbol: NSMCE1
NSMCE1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm 		0.010 PosttranslationalModification BEFREE The combination of NSE1 or SPOCK2 hypermethylation showed a sensitivity of 80% and specificity of 95% in differentiating cancer from normal. 18446232

2008